This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (12) Citing Articles via Google Scholar Google Scholar Articles by Iatrou, C. A. Articles by Dimitriou, V. K. Search for Related Content PubMed PubMed Citation Articles by Iatrou, C. A. Articles by Dimitriou, V. K. Related Collections Complications Regional Anesthesia Pain Pharmacology

---

REGIONAL ANESTHESIA

Prophylactic Intravenous Ondansetron and Dolasetron in Intrathecal Morphine-Induced Pruritus: A Randomized, Double-Blinded, Placebo-Controlled Study

Departments of Anesthesia and Surgery, Democritus University of Thrace, Alexandroupolis, Greece, and the Department of Anesthesia, "G. Gennimatas" Hospital, Athens, Greece

Address correspondence and reprint requests to Christos Dragoumanis MD, University Hospital of Alexandroupolis, Level 2, Room: 54.10, Dragana, Alexandroupolis 68100, Greece. Address e-mail to christosdr{at}panafonet.gr.

Pruritus is the most common side effect of intrathecal morphine for postoperative pain relief. Activation of central 5-hydroxytryptamine subtype 3 (5-HT3) receptors is one of its possible mechanisms. The role of 5-HT3 antagonists in the prevention of pruritus has not been clearly established. In a prospective, randomized, double-blind, placebo-controlled study, we evaluated the efficacy of prophylactic administration of ondansetron and dolasetron for the prevention of intrathecal morphine-induced pruritus. The patients were randomized into 3 groups to receive either 4 mg ondansetron IV (group O, n = 35), 12.5 mg dolasetron IV (group D, n = 35) or 5 mL placebo (group P, n = 35) 30 min before administration of spinal anesthesia with 10 to 17.5 mg of 0.5% hyperbaric bupivacaine and 0.25 mg of morphine for urologic, orthopedic, or vascular surgery. Patients were evaluated for incidence and severity of pruritus at arrival to the postanesthesia care unit and at 2, 4, 8, and 24 h postoperatively. The incidence and severity of pruritus was significantly less frequent in the ondansetron and dolasetron groups compared with placebo (34%, 20%, and 66% respectively, P < 0.01). Patients who received 5-HT3 antagonist reported significantly less total severity of pruritus compared with placebo during the first 8 h and the severe pruritus was observed only in patients within P group (P group: 4 of 35; 11%, O or D group: 0 of 35; 0%, P < 0.05). We conclude that the prophylactic use of ondansetron and dolasetron helps to reduce the incidence and severity of intrathecal morphine-induced pruritus.

This article has been cited by other articles:

				M.-P. Bonnet, E. Marret, J. Josserand, and F. J. Mercier Effect of prophylactic 5-HT3 receptor antagonists on pruritus induced by neuraxial opioids: a quantitative systematic review Br. J. Anaesth., September 1, 2008; 101(3): 311 - 319. [Abstract] [Full Text] [PDF]

				M. J. Sheen, S.-T. Ho, C.-H. Lee, Y.-C. Tsung, and F.-L. Chang Preoperative Gabapentin Prevents Intrathecal Morphine-Induced Pruritus After Orthopedic Surgery Anesth. Analg., June 1, 2008; 106(6): 1868 - 1872. [Abstract] [Full Text] [PDF]

				S. Eschertzhuber, M. Hohlrieder, C. Keller, E. Oswald, G. Kuehbacher, and P. Innerhofer Comparison of high- and low-dose intrathecal morphine for spinal fusion in children Br. J. Anaesth., April 1, 2008; 100(4): 538 - 543. [Abstract] [Full Text] [PDF]

				S. M. Siddik-Sayyid, M. T. Aouad, S. K. Taha, M. S. Azar, M. A. Hakki, R. N. Kaddoum, V. G. Nasr, V. G. Yazbek, and A. S. Baraka Does Ondansetron or Granisetron Prevent Subarachnoid Morphine-Induced Pruritus After Cesarean Delivery? Anesth. Analg., February 1, 2007; 104(2): 421 - 424. [Abstract] [Full Text] [PDF]

				M. Galea Morphine-induced pruritus after spinal anaesthesia. Br. J. Anaesth., September 1, 2006; 97(3): 426 - 426. [Full Text] [PDF]